| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.06 |